相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development of Novel Tetrahydroquinoline Inhibitors of NLRP3 Inflammasome for Potential Treatment of DSS-Induced Mouse Colitis
Zhen Dai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Design, synthesis and evaluation of 3-amide-5-aryl benzoic acid derivatives as novel P2Y14R antagonists with potential high efficiency against acute gouty arthritis
Ran Lu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
P2Y14 Receptor as a Target for Neutrophilia Attenuation in Severe COVID-19 Cases: From Hematopoietic Stem Cell Recruitment and Chemotaxis to Thrombo-inflammation
Lyvia Lintzmaier Petiz et al.
STEM CELL REVIEWS AND REPORTS (2021)
Immunopathogenesis and treatment of cytokine storm in COVID-19
Jae Seok Kim et al.
THERANOSTICS (2021)
P2Y14 receptor has a critical role in acute gouty arthritis by regulating pyroptosis of macrophages
Hanwen Li et al.
CELL DEATH & DISEASE (2020)
Glycogen metabolism regulates macrophage-mediated acute inflammatory responses
Jingwei Ma et al.
NATURE COMMUNICATIONS (2020)
Exploration of Alternative Scaffolds for P2Y14 Receptor Antagonists Containing a Biaryl Core
Young-Hwan Jung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Recent progress on the discovery of P2Y14 receptor antagonists
Ran Lu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Design, synthesis and anti-inflammatory evaluation of 3-amide benzoic acid derivatives as novel P2Y14 receptor antagonists
Zhenguo Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
The Pore-Forming Protein Gasdermin D Regulates Interleukin-1 Secretion from Living Macrophages
Charles L. Evavold et al.
IMMUNITY (2018)
Structure-Guided Modification of Heterocyclic Antagonists of the P2Y14 Receptor
Jinha Yu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Recently reported biological activities of pyrazole compounds
Jessica Venancia Faria et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Roles of Caspases in Necrotic Cell Death
Junying Yuan et al.
CELL (2016)
Structure-Based Design of 3-(4-Aryl-1H-1,2,3-triazol-1-yl)-Biphenyl Derivatives as P2Y14 Receptor Antagonists
Anna Junker et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Drug-like Antagonists of P2Y Receptors-From Lead Identification to Drug Development
Sean Conroy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
UDP-glucose promotes neutrophil recruitment in the lung
Juliana I. Sesma et al.
Purinergic Signalling (2016)
ASC filament formation serves as a signal amplification mechanism for inflammasomes
Mathias S. Dick et al.
NATURE COMMUNICATIONS (2016)
Purinergic regulation of the immune system
Caglar Cekic et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Renal Intercalated Cells Sense and Mediate Inflammation via the P2Y14 Receptor
Anie Azroyan et al.
PLoS One (2015)
UDP-Sugars as Extracellular Signaling Molecules: Cellular and Physiologic Consequences of P2Y14 Receptor Activation
Eduardo R. Lazarowski et al.
MOLECULAR PHARMACOLOGY (2015)
Exploring a 2-Naphthoic Acid Template for the Structure-Based Design of P2Y14 Receptor Antagonist Molecular Probes
Evgeny Kiselev et al.
ACS CHEMICAL BIOLOGY (2014)
IL-1 Blockade in Autoinflammatory Syndromes
Adriana A. Jesus et al.
ANNUAL REVIEW OF MEDICINE, VOL 65 (2014)
Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
Alvin Lu et al.
CELL (2014)
Recognition of Bacteria by Inflammasomes
Jakob von Moltke et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
A Selective High-Affinity Antagonist of the P2Y14 Receptor Inhibits UDP-Glucose-Stimulated Chemotaxis of Human Neutrophils
Matthew O. Barrett et al.
MOLECULAR PHARMACOLOGY (2013)
Multiple P2Y subtypes in spinal microglia are involved in neuropathic pain after peripheral nerve injury
Kimiko Kobayashi et al.
GLIA (2012)
GPR105 Ablation Prevents Inflammation and Improves Insulin Sensitivity in Mice with Diet-Induced Obesity
Jianfeng Xu et al.
JOURNAL OF IMMUNOLOGY (2012)
The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP
Geun-Shik Lee et al.
NATURE (2012)
Synthesis and SAR of pyrimidine-based, non-nucleotide P2Y14 receptor antagonists
Daniel Guay et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Applying the pro-drug approach to afford highly bioavailable antagonists of P2Y14
Joel Robichaud et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
The identification of 4,7-disubstituted naphthoic acid derivatives as UDP-competitive antagonists of P2Y14
Jacques Yves Gauthier et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
UDP-glucose acting at P2Y14 receptors is a mediator of mast cell degranulation
Zhan-Guo Gao et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Gi-Dependent Cell Signaling Responses of the Human P2Y14 Receptor in Model Cell Systems
Ingrid P. Fricks et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Quantification of Gi-Mediated Inhibition of Adenylyl Cyclase Activity Reveals That UDP Is a Potent Agonist of the Human P2Y14 Receptor
Rhonda L. Carter et al.
MOLECULAR PHARMACOLOGY (2009)
Molecular characteristics for solid-state limited solubility
Carola M. Wassvik et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Purine and pyrimidine receptors
G. Burnstock
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
International union of pharmacology LVIII: Update on the P2Y G protein-coupled nucleotide receptors: From molecular mechanisms and pathophysiology to therapy
Maria P. Abbracchio et al.
PHARMACOLOGICAL REVIEWS (2006)
Application of associative neural networks for prediction of lipophilicity in ALOGPS 2.1 program
IV Tetko et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2002)
Overview of P2Y receptors as therapeutic targets
JM Boeynaems et al.
DRUG DEVELOPMENT RESEARCH (2001)
A G protein-coupled receptor for UDP-glucose
JK Chambers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
